Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Bladder Tumors: - Molecular Aspects and Clinical Management (Hardcover, Edition.)
Loot Price: R5,513
Discovery Miles 55 130
|
|
Bladder Tumors: - Molecular Aspects and Clinical Management (Hardcover, Edition.)
Series: Cancer Drug Discovery and Development
Expected to ship within 10 - 15 working days
|
Clinical management of bladder cancer is challenging of the
heterogeneity among bladder tumors with respect to invasion and
metastasis, and frequent occurrence of new tumors in the bladder
among patients treated with bladder preservation treatments.
Treatment of bladder cancer spans from tumor resection and
intravesical treatment, to neoadjuvant chemotherapy, radical
surgery and adjuvant chemotherapy. At the same time, bladder cancer
is also at the forefront of biomarker development because of the
ease of developing noninvasive urine tests. The features of
environment-driven carcinogenesis and divergent molecular pathways
in the development of low- and high-grade tumors provide a unique
opportunity for advance molecular research in cancer biology.
Bladder Tumors: Molecular Aspects and Clinical Management is a
collection of comprehensive reviews on the state-of-the art basic
science research and clinical management of bladder cancer. The
book progresses from epidemiology of bladder cancer, molecular
basis of bladder carcinogenesis, to standard and molecular aspects
of bladder cancer diagnosis and prognosis, and also includes
various treatment aspects of both non muscle invasive and muscle
invasive bladder cancer. The book features: * Epidemiology, bladder
carcinogenesis and divergent molecular pathways of bladder cancer
development. * Pathology of bladder tumors, cystoscopy, cytology
and newer techniques of bladder cancer diagnosis. * Molecular
basis, efficacy and economics of diagnostic and prognostic markers
for bladder cancer, with an added feature of recent inventions of
molecular nomongrams. * Clinical management of low-grade and non
muscle invasive bladder tumors. * Intravesical chemotherapy versus
immune (BCG) therapy. * Clinical management of patients with muscle
invasive bladder cancer, including neoadjuvant therapy, various
aspects of cystectomy including urinary diversion and recent
advances such as laproscopic cystectomy * Ad
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.